American Century Companies’s Coherus Oncology CHRS Stock Holding History

American Century Companies’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$73.1K	Buy	+43,242	New	+$76.8K	﹤0.01%	2797
2022 Q2	–	Sell	-36,075	Closed	-$463K	–	2319
2022 Q1	$463K	Sell	36,075 -38,840	-52%	-$494K	﹤0.01%	1996
2021 Q4	$1.2M	Sell	74,915 -76	-0.1%	-$1.33K	﹤0.01%	1580
2021 Q3	$1.21M	Buy	74,991 +49,952	+199%	+$732K	﹤0.01%	1520
2021 Q2	$346K	Sell	25,039 -40,100	-62%	-$568K	﹤0.01%	1995
2021 Q1	$952K	Buy	65,139 +28,240	+77%	+$479K	﹤0.01%	1453
2020 Q4	$641K	Buy	36,899 +22,442	+155%	+$400K	﹤0.01%	1456
2020 Q3	$265K	Buy	+14,457	New	+$269K	﹤0.01%	1595

Other funds holding CHRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

American Century Companies's CHRS Position: Q1 2026 in Review

American Century Companies opened a new position in Coherus Oncology (CHRS) in Q1 2026: 43,242 shares worth $73.1K. The stake represents ﹤0.01% of the portfolio and ranks #2797 among its holdings. This is a return to the name: American Century Companies previously reported a position in CHRS as recently as Q1 2022.

American Century Companies first reported a position in CHRS in Q3 2020 and has held it in 8 quarters since. The position peaked at $1.21M in Q3 2021. 157 funds tracked by Wall St. Rank hold CHRS as of Q1 2026.

American Century Companies held 43,242 shares of Coherus Oncology worth $73.1K as of Q1 2026.
Coherus Oncology was a new American Century Companies position in Q1 2026.
Coherus Oncology made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2797 holding.
American Century Companies first reported a position in Coherus Oncology in Q3 2020 and has held it in 8 quarters since.
American Century Companies's Coherus Oncology position peaked at $1.21M in Q3 2021.
157 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.